Clinical Trials Logo

Clinical Trial Summary

Obesity is associated with general low grade inflammation and, consequently, of oxidative stress that affects properties and functionality of lipoproteins. Metabolic syndrome exacerbate low grade inflammation. The intentional weight loss of at least 5% of the initial weight can modulate the pro-inflammatory state and reduce the oxidative stress related to the metabolic syndrome, thus diminishing the cardiovascular risk.

Clinical Trial Description

Metabolic syndrome is a clustering of risk factors for the development of cardiovascular disease and type 2 diabetes mellitus. Patients with metabolic syndrome have an increased general low grade inflammation and, consequently, of oxidative stress that affects properties and functions of lipoproteins (Dandona et al 2005). Intentional weight loss can improve or prevent many of the metabolic syndrome-related risk factors and these benefits are often found after weight loss of at least 5% of initial weigh.

Aim: i) to investigate the structure and functionality of plasma lipoproteins, oxidative stress and the inflammatory condition in subjects with BMI between 25kg/mq and 35 kg/mq and with or without metabolic syndrome; and ii) to test the effects of weight loss of at least 5% of initial weigh promoted by an hypo-caloric balanced diet on these parameters.

Methods: Eighty overweight and moderately obese subjects (BMI: 25 - 35 kg/m2) with or without metabolic syndrome were recruited for the study. Fasting blood samples were taken and analyzed for routine laboratory analysis, lipoprotein isolation and analysis, and oxidative stress and inflammation markers measurements. The subjects received an hypo-caloric balanced diet. Fasting blood samples were taken from subjects who had lost at least 5% of their initial weight at the end of the intervention period and analyzed for same markers determined at baseline. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03553381
Study type Observational
Source University of Milan
Status Completed
Start date December 30, 2010
Completion date April 30, 2018

See also
  Status Clinical Trial Phase
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Recruiting NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Recruiting NCT03241121 - Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome N/A
Recruiting NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Recruiting NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Active, not recruiting NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Active, not recruiting NCT02252406 - Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome Phase 4
Active, not recruiting NCT02589756 - Fish or Nuts? Dietary Effects on Cardiometabolic Risk Factors and Persistent Organic Pollutants N/A
Completed NCT02867215 - Barley Bread and Metabolic Disease N/A
Active, not recruiting NCT02600338 - Meta-analyses of the Effect of Legumes on Blood Pressure N/A
Completed NCT03054779 - Canola Oil Multi-center Intervention Trial II N/A
Completed NCT02235805 - Magnesium and Vascular Stiffness N/A
Completed NCT02430987 - Prevalence of Metabolic Syndrome in Postmenopause Woman With Hypoactive Sexual Desire Disorder
Completed NCT01911078 - Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) N/A
Recruiting NCT01902654 - Osteoarthritis Cardiovascular Risk Factors N/A
Active, not recruiting NCT01906957 - Cognition and Exercise Training N/A
Not yet recruiting NCT01928355 - Cognitive Dysfunction in People Who Are Obese But Metabolically Healthy N/A
Withdrawn NCT01839864 - Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial N/A
Completed NCT01944579 - Blackberry Flavonoid Absorption and Effects on Intestinal Bacteria N/A